ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,538Medicare Part D Prescriptions Filled, Including Refills

Rank: 656 out of 2343

$410K Total Retail Price of All Prescriptions

Rank: 883 out of 2343

480 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 480 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

3% of this provider’s 7,135 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 385 333 1 1
AMLODIPINE BESYLATE 334 309 2 5
LEVOTHYROXINE SODIUM 287 255 3 2
METOPROLOL TARTRATE 270 240 4 7
LISINOPRIL 270 242 4 3
OMEPRAZOLE 252 201 6 4
FUROSEMIDE 196 186 7 6
ZOLPIDEM TARTRATE 195 143 8 24
METFORMIN HCL 185 140 9 9
LOVASTATIN 179 151 10 47
ATORVASTATIN CALCIUM 179 158 10 10
PRAVASTATIN SODIUM 174 138 12 15
HYDROCHLOROTHIAZIDE 174 153 12 11
METOPROLOL SUCCINATE 147 118 14 14
PANTOPRAZOLE SODIUM 130 129 15 22
WARFARIN SODIUM 128 127 16 8
FLUTICASONE PROPIONATE 125 100 17 46
ALENDRONATE SODIUM 112 112 18 28
ENALAPRIL MALEATE 112 98 18 58
SERTRALINE HCL 104 96 20 20
NEXIUM 103 79 21 33
LOSARTAN POTASSIUM 94 77 22 19
ATENOLOL 88 80 23 12
GLYBURIDE-METFORMIN HCL 87 87 R 24 154
SYNTHROID 80 70 25 40
AZITHROMYCIN 75 60 26 39
LOSARTAN-HYDROCHLOROTHIAZIDE 73 65 27 64
FAMOTIDINE 66 35 28 60
MIRTAZAPINE 65 64 29 41
MELOXICAM 64 63 30 68
ADVAIR DISKUS 62 54 31 34
GLYBURIDE 59 59 R 32 62
CITALOPRAM HBR 59 52 32 17
ACETAMINOPHEN-CODEINE 57 48 S3 34 112
OXYCODONE-ACETAMINOPHEN 56 47 S2 35 49
CARVEDILOL 55 48 36 27
IBUPROFEN 54 30 37 75
ZETIA 54 54 37 52
CLOTRIMAZOLE-BETAMETHASONE 53 42 39 127
OXYBUTYNIN CHLORIDE ER 51 51 40 149
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.